Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. CLARAMID (roxithromycine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

CLARAMID (roxithromycine)

Medicine - Posted on Mar 09 2011 - Updated on Jun 12 2019
Active substance (DCI)
  • roxithromycine
history (3)
  • 3/9/11

    CLARAMID (roxithromycine)

    CLARAMID (roxithromycine)
    icône flèche
  • 10/18/06

    CLARAMID (roxithromycine)

    CLARAMID (roxithromycine)
    icône flèche
  • 3/7/01

    CLARAMID 150 mg, comprimé enrobé (boîte de 16) CLARAMID ENFANT 100 mg, comprimé pelliculé (boîte de 16)

    CLARAMID 150 mg, comprimé enrobé (boîte de 16) CLARAMID ENFANT 100 mg, comprimé pelliculé (boîte de 16)
    icône flèche
Technical information
ATC code
  • J01FA06
Manufacturer
Laboratoire PFIZER
Presentation

CLARAMID ENFANTS 100 mg, comprimé pelliculé : Boîte de 10 - Code CIP : 3306952 / Boîte de 16 - Code CIP : 3458627

CLARAMID 150 mg, comprimé pelliculé : Boîte de 10 - Code CIP : 3290033 / Boîte de 16 - Code CIP : 3376013

All our publications
    Bacterial infections Bronchial diseases Drug therapy Female genital diseases Male genital diseases Nose and sinus diseases Paediatrics Phayngeal diseases Pulmonary and pleural diseases Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
BJ4sXURamKJ2A189